Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
0.8200
-0.0279 (-3.29%)
Jan 22, 2026, 4:00 PM EST - Market closed

Scinai Immunotherapeutics Revenue

Scinai Immunotherapeutics had revenue of $386.50K in the quarter ending June 30, 2025, with 36.09% growth. This brings the company's revenue in the last twelve months to $1.15M, up 303.87% year-over-year. In the year 2024, Scinai Immunotherapeutics had annual revenue of $658.00K.

Revenue (ttm)
$1.15M
Revenue Growth
+303.87%
P/S Ratio
0.94
Revenue / Employee
$37,000
Employees
31
Market Cap
2.84M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024658.00K--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jaguar Health11.79M
Ensysce Biosciences4.49M
Onconetix1.22M
HCW Biologics422.03K
Cardio Diagnostics Holdings15.78K
Azitra7.50K
Aditxt5.95K
Revenue Rankings